On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the ...

New technologies and care plans aim to enhance treatment options for patients in Mitchell and the surrounding area ...